Edition:
India

Soligenix Inc (SNGX.OQ)

SNGX.OQ on NASDAQ Stock Exchange Capital Market

1.74USD
24 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,412
52-wk High
$4.40
52-wk Low
$1.61

Chart for

About

Soligenix, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two segments: BioTherapeutics and Vaccines/BioDefense. Its BioTherapeutics segment is developing a photodynamic therapy (SGX301) utilizing topical... (more)

Overall

Beta: 2.19
Market Cap(Mil.): $13.11
Shares Outstanding(Mil.): 5.72
Dividend: --
Yield (%): --

Financials

BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning

* SOLIGENIX RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN COMMISSION FOR RIVAX® FOR PREVENTION OF RICIN POISONING Source text for Eikon: Further company coverage:

22 Mar 2018

BRIEF-Soligenix - Driving Towards Key Inflection Points With Two Pivotal Phase 3 Clinical Trials

* SOLIGENIX - DRIVING TOWARDS KEY INFLECTION POINTS WITH TWO PIVOTAL PHASE 3 CLINICAL TRIALS Source text for Eikon: Further company coverage:

25 Jan 2018

BRIEF-Soligenix Announces US Patent Issuance For Use Of Dusquetide In Oral Mucositis

* SOLIGENIX ANNOUNCES US PATENT ISSUANCE FOR USE OF DUSQUETIDE IN ORAL MUCOSITIS Source text for Eikon: Further company coverage:

02 Jan 2018

BRIEF-Soligenix Identifies Biomarkers For Ricin Toxin Vaccine Testing Under FDA Animal Rule

* SOLIGENIX IDENTIFIES BIOMARKERS FOR RICIN TOXIN VACCINE TESTING UNDER THE FDA ANIMAL RULE

21 Dec 2017

BRIEF-‍Knoll Capital Management LP​ reports a 9.9 pct passive stake in Soligenix as of Nov 2

* ‍Knoll Capital Management LP​ reports a 9.9 percent passive stake in Soligenix Inc as of Nov 2 - SEC Filing Source text: [http://bit.ly/2zVA43d] Further company coverage:

14 Nov 2017

BRIEF-‍ACT Capital Management reports 9.9 pct passive stake in Soligenix - SEC filing​

* ‍act Capital Management LLLP reports 9.9 percent passive stake in Soligenix Inc as of November 2, 2017 - SEC filing​ Source text: (http://bit.ly/2yFcZRO) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

08 Nov 2017

BRIEF-Soligenix reports Q3 loss per share $0.17

* Soligenix announces recent accomplishments and third quarter 2017 financial results

06 Nov 2017

BRIEF-Soligenix Inc announces pricing of offering

* Soligenix announces pricing of $5,115,000 concurrent registered direct offering and private placement of common stock priced above market

31 Oct 2017

Earnings vs. Estimates